# Lansen Pharmaceutical Holdings Limited
**Wikidata**: [Q11092335](https://www.wikidata.org/wiki/Q11092335)  
**Source**: https://4ort.xyz/entity/lansen-pharmaceutical-holdings-limited

## Summary
Lansen Pharmaceutical Holdings Limited (朗生醫藥控股有限公司) is a publicly traded company listed on the Hong Kong Stock Exchange (ticker: 0503). It operates as a pharmaceutical business, engaging in the development, manufacturing, and distribution of medical and healthcare products. As a public company, it offers its securities to the general public, enabling capital raising through investor ownership.

## Key Facts
- **Legal Name**: Lansen Pharmaceutical Holdings Limited (朗生醫藥控股有限公司)
- **Classification**: Public company, business entity
- **Stock Exchange Listing**: Hong Kong Stock Exchange (HKEX)
  - Ticker Symbol: 0503
  - Listing Date: May 7, 2010
- **Instance of**: Public company, joint-stock company
- **Aliases**:
  - 朗生醫藥控股
  - 朗生醫藥控股有限公司
- **Wikidata Sitelink Count**: 1 (Chinese Wikipedia)
- **Languages**: Primarily referenced in Chinese-language sources
- **Industry**: Pharmaceuticals, healthcare
- **Ownership**: Public shareholders (general public, institutional investors, etc.)
- **Governance**: Board of directors elected by shareholders

## FAQs
**What is Lansen Pharmaceutical Holdings Limited?**
Lansen Pharmaceutical Holdings Limited is a publicly traded pharmaceutical company listed on the Hong Kong Stock Exchange under ticker 0503. It operates in the healthcare sector, focusing on the production and distribution of medical products.

**How is Lansen Pharmaceutical Holdings Limited structured?**
As a public company, Lansen Pharmaceutical Holdings Limited is owned by shareholders who purchase its publicly traded securities. It is governed by a board of directors and must comply with regulatory disclosure requirements.

**When was Lansen Pharmaceutical Holdings Limited listed on the stock exchange?**
The company was listed on the Hong Kong Stock Exchange on May 7, 2010, under the ticker symbol 0503.

**What distinguishes Lansen Pharmaceutical Holdings Limited from private companies?**
Unlike private companies, Lansen Pharmaceutical Holdings Limited offers its shares to the general public, allowing open trading on the stock exchange. This structure enables broader capital raising but requires adherence to stricter regulatory and transparency standards.

**What is the primary industry of Lansen Pharmaceutical Holdings Limited?**
The company operates in the pharmaceutical and healthcare industry, engaging in the development, manufacturing, and distribution of medical and health-related products.

## Why It Matters
Lansen Pharmaceutical Holdings Limited plays a critical role in the global pharmaceutical industry by providing publicly accessible investment opportunities in healthcare innovation. As a public company, it contributes to capital formation, enabling large-scale funding for medical research, production, and distribution. Its listing on the Hong Kong Stock Exchange also enhances market liquidity, allowing investors to participate in the growth of the healthcare sector. Additionally, its compliance with regulatory standards ensures transparency, fostering investor confidence and corporate accountability.

## Notable For
- **Public Listing**: One of the pharmaceutical companies listed on the Hong Kong Stock Exchange, providing investment opportunities in the healthcare sector.
- **Regulatory Compliance**: Adheres to disclosure and reporting standards required for publicly traded companies, ensuring transparency for shareholders.
- **Capital Raising**: Leverages public markets to secure funding for business expansion, research, and development.
- **Industry Representation**: Represents the pharmaceutical sector in the public equity market, contributing to economic growth and healthcare accessibility.
- **Shareholder Ownership**: Distributes ownership among a broad base of investors, including individuals and institutions.

## Body

### **Corporate Identity and Classification**
Lansen Pharmaceutical Holdings Limited is formally recognized as a **public company**, a legal classification indicating that its securities (e.g., stocks) are available for purchase by the general public. This distinguishes it from private companies, which restrict ownership to a closed group of investors. The company is also classified as a **business entity**, operating within the pharmaceutical industry.

## **Stock Exchange Listing and Financial Details**
- **Exchange**: Hong Kong Stock Exchange (HKEX)
- **Ticker Symbol**: 0503
- **Listing Date**: May 7, 2010
- **Reference**: The HKEX profile page ([HKEX Listing Details](https://www.hkex.com.hk/eng/invest/company/profile_page_e.asp?WidCoID=0503&WidCoAbbName=&Month=&langcode=e)) confirms its public trading status and ticker symbol.

### **Ownership and Governance**
As a public company, Lansen Pharmaceutical Holdings Limited is owned by its **shareholders**, who may include:
- Individual investors
- Institutional investors (e.g., mutual funds, pension funds)
- Other corporate entities

Governance is structured around a **board of directors**, elected by shareholders to oversee corporate strategy, financial performance, and regulatory compliance. This separation of ownership (shareholders) and control (management) is a defining feature of public companies.

### **Industry and Business Operations**
Lansen Pharmaceutical Holdings Limited operates in the **pharmaceutical and healthcare sector**, though specific product lines, research focus, or therapeutic areas are not detailed in the provided source material. Public pharmaceutical companies typically engage in:
- Drug development and clinical trials
- Manufacturing of generic or proprietary medications
- Distribution and commercialization of medical products

### **Regulatory and Transparency Requirements**
Public companies like Lansen Pharmaceutical Holdings Limited are subject to **strict regulatory oversight**, including:
- **Financial Disclosures**: Quarterly and annual reporting (e.g., earnings, revenue, expenses)
- **Corporate Governance Standards**: Board composition, audit committees, shareholder rights
- **Market Regulations**: Compliance with HKEX listing rules and securities laws

These requirements ensure transparency for investors and reduce information asymmetry between the company and its shareholders.

### **Global Recognition and Language Representation**
- The company is primarily referenced in **Chinese-language sources**, as indicated by its single Wikidata sitelink (Chinese Wikipedia).
- The concept of a "public company" is globally recognized, with equivalents in multiple languages (e.g., "公開企業" in Japanese, "上櫃公司" in Chinese). However, Lansen Pharmaceutical Holdings Limited itself appears to have limited multilingual representation in public knowledge bases.

### **Comparison to Similar Entities**
Lansen Pharmaceutical Holdings Limited shares characteristics with other **publicly traded pharmaceutical companies**, such as:
- **Sinopharm Group** (listed on HKEX)
- **Shanghai Pharmaceuticals** (listed on HKEX and SSE)
- **Global peers**: Pfizer, Novartis, Roche (listed on NYSE, SIX, etc.)

Key differentiators may include:
- **Market Capitalization**: Size relative to competitors
- **Therapeutic Focus**: Specialization in certain drug classes (not specified in source)
- **Geographic Reach**: Primary markets served (e.g., China, international)

### **Economic and Social Impact**
As a public company, Lansen Pharmaceutical Holdings Limited contributes to:
- **Capital Markets**: Provides investment opportunities for retail and institutional investors.
- **Healthcare Access**: Supports the availability of medical products, though specific contributions are not detailed.
- **Job Creation**: Employs professionals in pharmaceutical research, manufacturing, and administration.
- **Economic Growth**: Generates tax revenue and stimulates ancillary industries (e.g., logistics, retail).

### **Limitations and Unknowns**
The provided source material does not include:
- **Founding Date**: When the company was established.
- **Revenue/Profit**: Financial performance metrics.
- **Key Products**: Specific drugs or medical devices manufactured.
- **Leadership**: Names of executives or board members.
- **Subsidiaries**: Whether it operates under a larger corporate group.

These details would require additional verification from corporate filings, financial reports, or official company disclosures.

## References

1. [Source](https://www.hkex.com.hk/eng/invest/company/profile_page_e.asp?WidCoID=0503&WidCoAbbName=&Month=&langcode=e)